Trials / Conditions / Locally Advanced Urethral Urothelial Carcinoma
Locally Advanced Urethral Urothelial Carcinoma
6 registered clinical trials studyying Locally Advanced Urethral Urothelial Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemo NCT04963153 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy NCT04637594 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Active Not Recruiting | Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or NCT04940299 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | ARID1A and/or KDM6A Mutation and CXCL13 Expression NCT04953104 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma NCT04848519 | Emory University | Phase 2 |
| Active Not Recruiting | Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metasta NCT03237780 | National Cancer Institute (NCI) | Phase 2 |